Raymond James analyst John Ransom maintained a Buy rating on Airsculpt Technologies, Inc. (AIRS – Research Report) today and set a price target of $8.00. The company’s shares closed last Friday at $4.40.
According to TipRanks, Ransom is a 5-star analyst with an average return of 10.3% and a 58.33% success rate. Ransom covers the Healthcare sector, focusing on stocks such as UnitedHealth, Oak Street Health, and Acadia Healthcare.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Airsculpt Technologies, Inc. with a $6.33 average price target.
See Insiders’ Hot Stocks on TipRanks >>
AIRS market cap is currently $247.2M and has a P/E ratio of -16.70.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
AirSculpt Technologies Inc is a provider of body contouring procedures delivering a premium consumer experience. It provides a custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure, producing dramatic results. Its mission is to generate the best results for patients.
Read More on AIRS:
- AirSculpt Technologies Announces Fourth Quarter 2022 Results and Provides 2023 Guidance
- AirSculpt Technologies sees FY23 revenue $187M-$192M, consensus $202.42M
- AirSculpt Technologies sees Q1 revenue $43M, consensus $45.98M
- AirSculpt Technologies reports Q4 EPS (13c), consensus (3c)
- AirSculpt Technologies Announces Fourth Quarter 2022 Earnings Release Date and Conference Call
